Track topics on Twitter Track topics that are important to you
The European Medicines Agency has now issued a green light for Shire's pancreatic therapy Onivyde, following its US approval in July this year.
Original Article: EU green light for Shire’s pancreatic cancer drug OnivydeNEXT ARTICLE
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake. Diagnosis is based on clinical presentation...